VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 9)

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 9)

Professional Development

6 Qs

quiz-placeholder

Similar activities

PR Online 1er trimestre

PR Online 1er trimestre

Professional Development

10 Qs

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 5)

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 5)

Professional Development

7 Qs

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 4)

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 4)

Professional Development

4 Qs

PR Online 2do trimestre

PR Online 2do trimestre

Professional Development

10 Qs

WEBINAR ASPEK FISIKA

WEBINAR ASPEK FISIKA

Professional Development

7 Qs

Chapter 15 True and False Questions

Chapter 15 True and False Questions

KG - Professional Development

10 Qs

Higiene Industrial y Radiaciones Ionizantes

Higiene Industrial y Radiaciones Ionizantes

Professional Development

10 Qs

RADIATION PROTECTION

RADIATION PROTECTION

Professional Development

8 Qs

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 9)

VIII.3. Nuclear Medicine: Diagnosis and Therapy (LO 9)

Assessment

Quiz

Physics

Professional Development

Medium

Created by

UMMI (IKN)

Used 5+ times

FREE Resource

6 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

1) Who is responsible for ensuring that a patient is not discharged until the radionuclide activity is at a safe level?

A) Radiological medical practitioner

B) Medical physicist or radiation protection officer

C) Nurse on duty

D) Hospital administrator

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

2) Which of the following groups is NOT considered at risk of exposure after a patient is released from radiopharmaceutical therapy?

A) Hospital staff

B) Family members

C) Public transport passengers

D) Co-workers

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

3) In what scenario would a higher effective dose in a single year be acceptable for public exposure?

A) Under no circumstances

B) If the average effective dose over five consecutive years does not exceed 1 mSv per year

C) If the patient signs a waiver

D) Only in case of a national emergency

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

4) What dose constraint is commonly used for adult carers or comforters during the care of a patient who has undergone radiopharmaceutical therapy?

A) 1 mSv

B) 5 mSv

C) 15 mSv

D) 50 mSv

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

5) What should be taken into consideration before releasing a patient after radiopharmaceutical therapy?

A) The cost of the therapy

B) The patient's insurance coverage

C) The patient’s living conditions and potential exposure to others

D) The patient's preference for staying longer in the hospital

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

6) What is the effective dose limit for the general public per year according to the provided document?

A) 0.3 mSv

B) 1 mSv

C) 5 mSv

D) 50 mSv